• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unveiling the potential of natural compounds in the fight against obesity.

作者信息

Jia Ziwen, Lu Sijia, Chen Suzhen, Liu Junli

机构信息

Lab of Metabolism and Aging, School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.

Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital, Shanghai, 200233, China.

出版信息

Metabol Open. 2024 Jan 11;22:100271. doi: 10.1016/j.metop.2024.100271. eCollection 2024 Jun.

DOI:10.1016/j.metop.2024.100271
PMID:39011165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247220/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5599/11247220/05e1c4d1dc3d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5599/11247220/05e1c4d1dc3d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5599/11247220/05e1c4d1dc3d/gr1.jpg

相似文献

1
Unveiling the potential of natural compounds in the fight against obesity.揭示天然化合物在对抗肥胖方面的潜力。
Metabol Open. 2024 Jan 11;22:100271. doi: 10.1016/j.metop.2024.100271. eCollection 2024 Jun.
2
Unveiling the Potential of Natural Compounds: A Comprehensive Review on Adipose Thermogenesis Modulation.揭示天然化合物的潜力：脂肪细胞产热调控的综合综述。
Int J Mol Sci. 2024 Apr 30;25(9):4915. doi: 10.3390/ijms25094915.
3
Multimodal Strategies to Fight Obesity: Research on Tailored Therapies Based on Natural and Synthetic Compounds for Prevention, Management and Treatment.多模态策略防治肥胖：基于天然和合成化合物的个体化治疗的预防、管理和治疗研究。
Int J Mol Sci. 2023 Jun 14;24(12):10105. doi: 10.3390/ijms241210105.
4
Potential anti-obesity/inflammatory flavonoid-derived biomolecules against Obesity to prevent WAT differentiation by targeting a DNA-binding protein inhibitor, ID-1.针对肥胖症的潜在抗肥胖/炎症黄酮类生物分子，通过靶向 DNA 结合蛋白抑制剂 ID-1 来预防 WAT 分化。
Cell Mol Biol (Noisy-le-grand). 2023 May 31;69(5):150-155. doi: 10.14715/cmb/2023.69.5.23.
5
Unveiling six potent and highly selective antileishmanial agents via the open source compound collection 'Pathogen Box' against antimony-sensitive and -resistant Leishmania braziliensis.揭示六种强效且高选择性的抗利什曼原虫化合物，这些化合物来自开源化合物库“病原体盒”，可对抗对锑敏感和耐药的巴西利什曼原虫。
Biomed Pharmacother. 2021 Jan;133:111049. doi: 10.1016/j.biopha.2020.111049. Epub 2020 Dec 4.
6
anti-HCoV: A web resource to collect natural compounds against human coronaviruses.抗人冠状病毒：一个收集抗人冠状病毒天然化合物的网络资源。
Trends Food Sci Technol. 2020 Dec;106:1-11. doi: 10.1016/j.tifs.2020.09.007. Epub 2020 Sep 22.
7
Potential effects of sulforaphane to fight obesity.莱菔硫烷对抗肥胖的潜在作用。
J Sci Food Agric. 2018 Jun;98(8):2837-2844. doi: 10.1002/jsfa.8898. Epub 2018 Mar 7.
8
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders.探索治疗前沿：揭示天然二萜类衍生物在治疗神经系统疾病中的潜力。
Curr Pharm Biotechnol. 2024 May 17. doi: 10.2174/0113892010304266240507050825.
9
From himachalenes to trans-himachalol: unveiling bioactivity through hemisynthesis and molecular docking analysis.从喜马拉雅烯到反式喜马拉雅醇：通过半合成和分子对接分析揭示生物活性。
Sci Rep. 2023 Oct 17;13(1):17653. doi: 10.1038/s41598-023-44652-z.
10
Intermittent fasting for obesity and related disorders: unveiling myths, facts, and presumptions.间歇性禁食治疗肥胖及相关疾病：揭开迷思、事实与臆测。
Arch Endocrinol Metab. 2021 Nov 1;65(1):14-23. doi: 10.20945/2359-3997000000322. Epub 2021 Jan 14.

本文引用的文献

1
Natural compounds as obesity pharmacotherapies.天然化合物作为肥胖症的药物疗法。
Phytother Res. 2024 Feb;38(2):797-838. doi: 10.1002/ptr.8083. Epub 2023 Dec 11.
2
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.胰高血糖素样肽-1受体激动剂用于减肥时胃肠道不良事件的风险
JAMA. 2023 Nov 14;330(18):1795-1797. doi: 10.1001/jama.2023.19574.
3
The combined effect of metformin and mirabegron on diet-induced obesity.二甲双胍和米拉贝隆对饮食诱导肥胖的联合作用。
MedComm (2020). 2023 Feb 14;4(2):e207. doi: 10.1002/mco2.207. eCollection 2023 Apr.
4
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.成人超重和肥胖的药物治疗：随机对照试验的系统评价和网状荟萃分析
Lancet. 2022 Jan 15;399(10321):259-269. doi: 10.1016/S0140-6736(21)01640-8. Epub 2021 Dec 8.
5
Anti-obesity drug discovery: advances and challenges.抗肥胖药物的发现：进展与挑战。
Nat Rev Drug Discov. 2022 Mar;21(3):201-223. doi: 10.1038/s41573-021-00337-8. Epub 2021 Nov 23.
6
Natural products in drug discovery: advances and opportunities.天然产物在药物发现中的应用：进展与机遇。
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28.
7
Effects and mechanisms of edible and medicinal plants on obesity: an updated review.食用和药用植物对肥胖的影响及其作用机制：最新综述。
Crit Rev Food Sci Nutr. 2021;61(12):2061-2077. doi: 10.1080/10408398.2020.1769548. Epub 2020 May 28.
8
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease.用于治疗非酒精性脂肪性肝病的草药药物发现
Acta Pharm Sin B. 2020 Jan;10(1):3-18. doi: 10.1016/j.apsb.2019.11.017. Epub 2019 Dec 10.
9
Effectiveness of herbal medicines for weight loss: A systematic review and meta-analysis of randomized controlled trials.草药减肥药的疗效：一项随机对照试验的系统评价和荟萃分析。
Diabetes Obes Metab. 2020 Jun;22(6):891-903. doi: 10.1111/dom.13973. Epub 2020 Feb 15.
10
Effect of the herbal medicines in obesity and metabolic syndrome: A systematic review and meta-analysis of clinical trials.中草药在肥胖和代谢综合征中的作用：临床试验的系统评价和荟萃分析。
Phytother Res. 2020 Mar;34(3):526-545. doi: 10.1002/ptr.6547. Epub 2019 Dec 2.